Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.95 +0.08 (+4.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Polaryx Therapeutics (PLYX) Cash from Operations (2025 - 2026)

Updated

Polaryx Therapeutics (PLYX) posted Cash from Operations of -$1.33 million for Q2 2026, compared with -$891,000 a year earlier.

Analysis

Polaryx Therapeutics (PLYX) Cash from Operations (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Operations at Polaryx Therapeutics was -$5.03 million; for FY2025, it was -$3.94 million.

  • In prior years, Polaryx Therapeutics' Cash from Operations was -$2.6 million in FY2024.
  • Quarterly Cash from Operations has run from a low of -$2.1 million in Q1 2026 to a high of -$709,000 in Q1 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 11.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 7.72 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.61 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.67 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 4.24 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.04 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.38 Bn
10 Polaryx Therapeutics 93.21 Mn 68.83 Mn - -1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.33 Mn
Mar 31, 2026 -2.10 Mn
Jun 30, 2025 -891,000.00
Mar 31, 2025 -709,000.00
API Access

Polaryx Therapeutics Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=PLYX&period=max&api_key=YOUR_API_KEY